DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Raltitrexed
Raltitrexed
A Phase II Study of the Novel Proteasome Inhibitor Bortezomib In
Clinical Efficacy of Irinotecan Plus Raltitrexed
Diarrhea Increased with Targeted Cancer Agents
(12) Patent Application Publication (10) Pub. No.: US 2013/0211215 A1 Heglund Et Al
Clinical Outcomes of Doxorubicin-Eluting Callispheres
BC Cancer Benefit Drug List September 2021
Comparison of E Cacy and Safety of Second-Line
The Value of Pemetrexed for the Treatment of Malignant Pleural Mesothelioma: a Comprehensive Review CHRISTEL C.L.M
Pharmaceuticals As Environmental Contaminants
Wear the Battle Gear That Protects Against 52 Chemotherapy Drugs!
DRUG NAME: Raltitrexed
Valproate–Doxorubicin: Promising Therapy for Progressing Mesothelioma
Carboplatin in Combination with Raltitrexed
Recommendations for the Adjustment of Dosing in Elderly Cancer Patients with Renal Insufficiency
CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS
For Health Professionals Who Care for Cancer Patients
2548.Full-Text.Pdf
CEA Fluctuation During a Single Fluorouracil-Based Chemotherapy Cycle for Metastatic Colorectal Cancer
Top View
NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010
Biweekly Oxaliplatin, Raltitrexed, 5-Fluorouracil and Folinic Acid Combination Chemotherapy During Preoperative Radiation Therap
Electronic Supplementary Material (ESI) for Lab on a Chip. This Journal Is © the Royal Society of Chemistry 2020
2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
Induces Thymineless Death with Topoisomerase I-DNA Complexes
Activity and Toxicity of Oxaliplatin Plus Raltitrexed in 5-Fluorouracil Refractory Metastatic Colorectal Adeno-Carcinoma
Pre-Operative Radiochemotherapy with Raltitrexed for Resectable Locally-Advanced Rectal Cancer: a Phase II Study*
Formulation of Folate-Modified Raltitrexed-Loaded Nanoparticles
Hair Loss and Chemotherapy
MANUAL for Medical Facilities
Cytochrome P450 1B1 Gene Polymorphisms As Predictors of Anticancer Drug Activity: Studies with in Vitro Models
Management of Extravasation of a Systemic Anti-Cancer Therapy Including Cytotoxic Agents
EMA/PDCO Summary Report on the Review of the List of Granted Class Waivers
SAHA Overcomes 5-FU Resistance in IFIT2-Depleted Oral Squamous Cell Carcinoma Cells
Schedule-Dependent Synergism and Antagonism Between Methotrexate
Oncology Agents Not Listed in Seer Book 8
Selective Preservation of Pemetrexed
Phase I Trial and Pharmacokinetic Study of Raltitrexed in Children with Recurrent Or Refractory Leukemia: a Pediatric Oncology Group Study
BC Cancer Drug Benefit List
A Systematic Review of Photodynamic Therapy in the Treatment of Pre
A Dose-Finding Study of Raltitrexed (Tomudex)
DRUG NAME: Leucovorin
Immunogenic Cell Death and Elimination of Immunosuppressive Cells: a Double-Edged Sword of Chemotherapy
Antitumor Effect and Potentiation of Cytotoxic Drugs Activity in Human
Alimta, INN-Pemetrexed
Dose Rounding July 2016
Thames Valley Chemotherapy Regimens Colorectal Cancer
Product Monograph Tomudex®
NIOSH Alert: Preventing Occupational Exposures to Antineoplastic
Pdf 471.32 K
DRUG NAME: Pemetrexed
Raltitrexed As a Synergistic Hyperthermia Chemotherapy Drug Screened in Patient-Derived Colorectal Cancer Organoids
February 5, 2019 O & M Halyard, Inc. Angela Bunn Director of Regulatory Affairs 5405 Windward Parkway Alpharetta, Georgia 30
Comparison of Transcatheter Arterial Chemoembolization with Raltitrexed Plus Liposomal Doxorubicin Vs
Anticancer Drugs for Intra-Arterial Treatment of Colorectal Cancer Liver Metastases: In-Vitro Screening After Short Exposure Time
Inhibition of Proteasome by Bortezomib Increase Chemosensitivity of Bcr/Abl Positive Human K562 Chronic Myleoid Leukemia Cells to Imatinib
Hazardous Drug List
Renal Impairment Hepatic Impairment Agent PK Summary Available
Medications That Are Considered Hazardous
Procarbazine Hydrochloride
Sequencing of Antineoplastic Drug Administration: Contributions to Evidence-Based Oncology Nursing Practice
Raltitrexed Induces Mitochondrial‑Mediated Apoptosis in SGC7901 Human Gastric Cancer Cells
Efficacy of a Fluoropyrimidine Plus Mitomycin C in Pretreated Patients with Metastatic Colorectal Cancer Eligible for Regorafenib: a Retrospective Study